Other studies demonstrated that ASC administration was sufficient to attenuate BLM-induced scleroderma by suppressing the infiltration of CD4+ and CD8+ T cells and macrophages into the dermis, but it also reduced the frequency of CD4+ T cells and effector B cells in the spleens of SS mice [247]. The gene discussed is CD4; the disease is scleroderma.